| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 09/16/2004 | WO2004078729A1 Process for the production of substituted nicotinic acid esters |
| 09/16/2004 | WO2004078103A2 G-lactam derivatives as prostaglandin agonists |
| 09/16/2004 | WO2004062562A3 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 09/16/2004 | WO2004058149A3 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles |
| 09/16/2004 | WO2004056769A3 Synthesis of amines and intermediates for the synthesis thereof |
| 09/16/2004 | WO2004052855A3 Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 09/16/2004 | WO2004052853A3 Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 09/16/2004 | WO2004050653A3 Oxime ester photoinitiators with heteroaromatic groups |
| 09/16/2004 | WO2004047739A3 Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers |
| 09/16/2004 | WO2004043389B1 Methods of treating cancer and related methods |
| 09/16/2004 | WO2004026264A3 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 09/16/2004 | WO2003028729A3 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/16/2004 | US20040181075 Process of making chalcone derivatives |
| 09/16/2004 | US20040181073 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils |
| 09/16/2004 | US20040181068 and ras protein farnesylation; anti-cancer agents; also act as inhibitors of other prenyl transferases |
| 09/16/2004 | US20040181067 Tri(cyclo) substituted amide compounds |
| 09/16/2004 | US20040181062 Benzimidazole cyclooxygenase-2 inhibitor |
| 09/16/2004 | US20040180947 Sulfonamide compounds and pharmaceutical use thereof |
| 09/16/2004 | US20040180936 having an inhibitory activity on calpains and/or a trapping activity on reactive oxygen species; inflammatory and immunological diseases; disorders of the central or peripheral nervous system |
| 09/16/2004 | US20040180914 5-Cyano-2-aminopyrimidine derivatives |
| 09/16/2004 | US20040180905 for treating cancer and fibrotic diseases |
| 09/16/2004 | US20040180902 3-Substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 09/16/2004 | US20040180901 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 09/16/2004 | US20040180899 tyrosine kinase inhibitors |
| 09/16/2004 | US20040180892 control of cardiovascular homeostasis is achieved through a combination of both direct neuronal control and systemic neurohormonal activation |
| 09/16/2004 | US20040180891 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders |
| 09/16/2004 | US20040180887 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/16/2004 | US20040180885 Indole derivatives, process for preparation of the same and use thereof |
| 09/16/2004 | US20040180882 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 09/16/2004 | US20040180877 Nicotinic acetylcholine receptor cholinergic ligands, monoamine receptor and transporter modulators; such as 1-(2-Benzo[b]thiophenyl-1,1-dioxide)-imidazolidine |
| 09/16/2004 | CA2517844A1 Quinazolines useful as modulators of ion channels |
| 09/16/2004 | CA2517088A1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
| 09/16/2004 | CA2516931A1 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |
| 09/16/2004 | CA2513652A1 G-lactam derivatives as prostaglandin agonists |
| 09/16/2004 | CA2512243A1 N-aryl heteroaromatic products, compositions containing same and use thereof |
| 09/15/2004 | EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 09/15/2004 | EP1457488A1 Intermediates for use in the preparation of urea compounds having muscarinic receptor antagonist activity |
| 09/15/2004 | EP1456205A1 Imidazoquinoline derivatives |
| 09/15/2004 | EP1456198A1 Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases |
| 09/15/2004 | EP1456196A1 Benzothiophenes as adenosine receptor modulators |
| 09/15/2004 | EP1456182A1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i) |
| 09/15/2004 | EP1456180A1 3,4-diarylpyrazoles and their use in the therapy of cancer |
| 09/15/2004 | EP1456176A1 Improved compounds for generating chemiluminescence with a peroxidase |
| 09/15/2004 | EP1456172A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 09/15/2004 | EP1455787A1 Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders |
| 09/15/2004 | EP1455777A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 09/15/2004 | EP1341746B1 Liquid crystalline compounds |
| 09/15/2004 | EP1295878B1 Pyrazinone derivatives |
| 09/15/2004 | EP1254135B1 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 09/15/2004 | EP1185526B1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use |
| 09/15/2004 | EP1019398B1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 09/15/2004 | EP1000932B1 Aromatic ring derivatives |
| 09/15/2004 | CN1529703A 新的吲哚衍生物 The new indole derivatives |
| 09/15/2004 | CN1529697A Tricyclic compounds useful as angiotensin II agonists |
| 09/15/2004 | CN1529601A 四氢喹啉衍生物 Tetrahydroquinoline derivative |
| 09/15/2004 | CN1529595A 4,5-hydro-1H-pyrazole derivative having protent CB1-antagonistic |
| 09/15/2004 | CN1166658C 4,5-diaryl-3(i(2H))-furanone derivatives as cyclooxygenase-2 inhibitors |
| 09/15/2004 | CN1166638C Novel benzo-[3,4] cyclobutano [1,2-C] pyrroles compound, its prepn. and medicine composition containing the same |
| 09/15/2004 | CN1166635C Trifuoro methylpyrrol carboxamides |
| 09/15/2004 | CN1166629C Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same |
| 09/14/2004 | US6790860 Pyrrolidine derivatives |
| 09/14/2004 | US6790858 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone |
| 09/14/2004 | US6790852 Heterocyclic nitrogen compounds such as 2-(2,6-dichlorophenyl) -4-(3-bromophenyl)-5-(2-(3- hydroxypropylamino)pyrimidin-4-yl) -n-h-imidazole, used as tyrosine kinase inhibitors; anticarcinogenic or antitumor agents |
| 09/14/2004 | US6790844 Muscle relaxants; antiserotonine agent |
| 09/14/2004 | CA2315826C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 09/10/2004 | WO2004076446A1 Benzothiophene derivative |
| 09/10/2004 | WO2004076433A1 Dipeptidyl peptidase inhibitors |
| 09/10/2004 | WO2004076424A1 Heterocyclic kinase inhibitors |
| 09/10/2004 | WO2004076421A1 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides |
| 09/10/2004 | WO2004076418A1 Ligands that modulate lxr-type receptors |
| 09/10/2004 | WO2004076412A2 Aminoheteroaryl compounds as protein kinase inhibitors |
| 09/10/2004 | WO2004075840A2 Selective non-steroidal glucocorticoid receptor modulators |
| 09/10/2004 | WO2004075815A2 Diarylcycloalkyl derivatives, method for their production and their use as medicaments |
| 09/10/2004 | WO2004056755A3 Compounds for the inhibition of non-proteolytic enzymes |
| 09/10/2004 | WO2004056727A8 Process of making chalcone derivatives |
| 09/10/2004 | WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators |
| 09/10/2004 | WO2004050643A3 Non-nucleoside reverse transcriptase inhibitors |
| 09/10/2004 | WO2004047769A3 Benzimidazoles and analogs thereof as antibacterials |
| 09/10/2004 | WO2004041776A3 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS |
| 09/10/2004 | WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 09/10/2004 | CA2517256A1 Aminoheteroaryl compounds as protein kinase inhibitors |
| 09/10/2004 | CA2516684A1 Selective non-steroidal glucocorticoid receptor modulators |
| 09/10/2004 | CA2516573A1 Diarylcycloalkyl derivatives, method for their production and their use as medicaments |
| 09/10/2004 | CA2512886A1 Ligands that modulate lxr-type receptors |
| 09/09/2004 | US20040176605 Compounds as antumor agents or immunosuppressants |
| 09/09/2004 | US20040176603 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
| 09/09/2004 | US20040176602 3-Cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 09/09/2004 | US20040176599 Generating chemiluminescence by reaction with peroxidase compound and detection of signal with analyzing compound |
| 09/09/2004 | US20040176594 Drugs that inhibit phosphorylation kinases as an antigrowth or antiproliferation agent |
| 09/09/2004 | US20040176461 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
| 09/09/2004 | US20040176438 Novel mono- and di-fluorinated beozothiepine copmunds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake |
| 09/09/2004 | US20040176434 Pyrazoloanthrone derivatives as Jun N-terminal kinase inhibitors; diabetes; obesity |
| 09/09/2004 | US20040176433 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 09/09/2004 | US20040176428 treatment of Type 2 diabetes mellitus, obesity and lipid disorders; coadministration with HMG CoA reductase inhibitors |
| 09/09/2004 | US20040176422 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 09/09/2004 | US20040176411 especially useful for treating asthma and/or rhinitis; example compound N-[[[2-[4-(3,4-dichlorophenoxy)-1-piperidinyl]ethyl]amino]carbonyl]-4-methyl-benzenesulfonamide |
| 09/09/2004 | US20040176389 Piperazine oxime dervatives having nk-1 receptor antagonistic activity |
| 09/09/2004 | US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori |
| 09/09/2004 | US20040176377 inhibitors of glycogen synthase kinase-3 beta; treatment of diabetes or neurodegenerative diseases such as Alzheimer's disease; 6-(2-butylamino-pyrimidin-4-yl)-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid (3-pyridin-3-yl-propyl)-amide, as example |
| 09/09/2004 | US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants |